Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036373 | 12603637 | 3 | F | 201604 | 20160907 | 20160728 | 20160909 | PER | US-PFIZER INC-2016356715 | PFIZER | 55.00 | YR | F | Y | 101.15000 | KG | 20160909 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036373 | 12603637 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 1X/DAY | C140333 | 20998 | 200 | MG | CAPSULE, HARD | QD | |||||
| 126036373 | 12603637 | 2 | SS | CELEBREX | CELECOXIB | 1 | Oral | 100 MG, 2X/DAY | 20998 | 100 | MG | CAPSULE, HARD | BID | ||||||
| 126036373 | 12603637 | 3 | C | GABAPENTIN. | GABAPENTIN | 1 | 1200 MG, DAILY (4X A DAY) (DAILY) | 0 | 1200 | MG | QID | ||||||||
| 126036373 | 12603637 | 4 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 126036373 | 12603637 | 5 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126036373 | 12603637 | 6 | C | DIAZEPAM. | DIAZEPAM | 1 | 15 MG, DAILY | 0 | 15 | MG | |||||||||
| 126036373 | 12603637 | 7 | C | DIAZEPAM. | DIAZEPAM | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 126036373 | 12603637 | 8 | C | ROZEREM | RAMELTEON | 1 | 8 MG, DAILY | 0 | 8 | MG | TABLET | ||||||||
| 126036373 | 12603637 | 9 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 25 MG, DAILY | 0 | 25 | MG | |||||||||
| 126036373 | 12603637 | 10 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 126036373 | 12603637 | 11 | C | OXYCODONE | OXYCODONE | 1 | 60 MG, DAILY | 0 | 60 | MG | |||||||||
| 126036373 | 12603637 | 12 | C | TYLENOL | ACETAMINOPHEN | 1 | 4000 MG, DAILY | 0 | 4000 | MG | |||||||||
| 126036373 | 12603637 | 13 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 10 MG, 3X/DAY | 0 | 10 | MG | TID | ||||||||
| 126036373 | 12603637 | 14 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 12 MG, DAILY | 0 | 12 | MG | |||||||||
| 126036373 | 12603637 | 15 | C | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, DAILY | 0 | 1 | MG | |||||||||
| 126036373 | 12603637 | 16 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 126036373 | 12603637 | 17 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 30 MG, DAILY | 0 | 30 | MG | |||||||||
| 126036373 | 12603637 | 18 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | 500 MG, DAILY (500 MG DAILY FOR 1 WK ) | 0 | 500 | MG | |||||||||
| 126036373 | 12603637 | 19 | C | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | 1000 MG, UNK (1000 MG THEREAFTER) | 0 | 1000 | MG | |||||||||
| 126036373 | 12603637 | 20 | C | LUMIGAN | BIMATOPROST | 1 | 0.1 %, UNK | 0 | .1 | PCT | |||||||||
| 126036373 | 12603637 | 21 | C | SYSTANE (HYPROMELLOSE 2910 (4000 MPA.S)) | HYPROMELLOSE 2910 (4000 MPA.S) | 1 | 1 GTT, UNK | 0 | 1 | GTT | |||||||||
| 126036373 | 12603637 | 22 | C | BISACODYL. | BISACODYL | 1 | 10 MG, AS NEEDED | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126036373 | 12603637 | 1 | Inflammation |
| 126036373 | 12603637 | 3 | Anxiety |
| 126036373 | 12603637 | 4 | Depression |
| 126036373 | 12603637 | 5 | Sleep disorder |
| 126036373 | 12603637 | 6 | Anxiety |
| 126036373 | 12603637 | 8 | Sleep disorder |
| 126036373 | 12603637 | 9 | Depression |
| 126036373 | 12603637 | 10 | Anxiety |
| 126036373 | 12603637 | 11 | Pain |
| 126036373 | 12603637 | 13 | Myalgia |
| 126036373 | 12603637 | 14 | Pain |
| 126036373 | 12603637 | 16 | Blood cholesterol |
| 126036373 | 12603637 | 17 | Inflammation |
| 126036373 | 12603637 | 21 | Dry eye |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126036373 | 12603637 | Anxiety | |
| 126036373 | 12603637 | Heart rate increased | |
| 126036373 | 12603637 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126036373 | 12603637 | 1 | 201604 | 201604 | 0 |